In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

PanEcho isn’t yet ready to be a standalone tool, researchers say, but shows promise at improving workflows and patient care.

There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better ...

ABSTRACT. Introduction: The clinical significance of new-onset left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) remains controversial.In the presented study, we ...

The prevalence of aortic stenosis (AS) and amyloid transthyretin cardiomyopathy (ATTR‐CM) increases with age. While the global prevalence of calcific aortic valve disease is estimated to be >2% in ...

I see screening tests advertised often. For $160, I can get screened for conditions that might cause strokes, heart disease, ...

Aortic stenosis is 1 of the most common heart valve diseases among adults. When symptoms develop, prognosis is poor, and current guidelines recommend prompt aortic valve replacement. Depending of the ...

Objective To evaluate the effect of age and aortic valve anatomy (tricuspid (TAV) vs bicuspid (BAV) aortic valve) on the relationship between the aortic valve calcification (AVC) and the haemodynamic ...

Objective Aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) is associated with a poor clinical outcome and its assessment therefore crucial. Quantification of AR by ...

Calcified aortic valve stenosis, the most common acquired valvular pathology, often occurs in patients of advanced age, who are also at higher risk for atherosclerotic disease. As the population ages, ...